Publikationen, an denen er mitarbeitet María Inmaculada Colina Lorda (16)

2024

  1. Evaluation of measured and calculated small dense low-density lipoprotein in capillary blood and association with the metabolic syndrome

    Clinica Chimica Acta, Vol. 557

2023

  1. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

    Metabolism: Clinical and Experimental, Vol. 147

2020

  1. Exploring the association between emphysema phenotypes and low bone mineral density in smokers with and without copd

    International Journal of COPD, Vol. 15, pp. 1823-1829

  2. Ghrelin Reduces TNF-α-Induced Human Hepatocyte Apoptosis, Autophagy, and Pyroptosis: Role in Obesity-Associated NAFLD

    Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 1, pp. 21-37

2019

  1. Trabecular bone score and bone remodelling markers identify perimenopausal women at high risk of bone loss

    Clinical Endocrinology, Vol. 91, Núm. 3, pp. 391-399

  2. Trabecular bone score in active or former smokers with and without COPD

    PLoS ONE, Vol. 14, Núm. 2

2014

  1. Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification

    Clinical Biochemistry, Vol. 47, Núm. 18, pp. 272-278

2013

  1. Erratum: Traditional and novel bone remodeling markers in premenopausal and postmenopausal women (Journal of Clinical Endocrinology and Metabolism (2013) 98 (E1740-E1748) DOI:10.1210/jc.2013-2264)

    Journal of Clinical Endocrinology and Metabolism

  2. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 11

2012

  1. The ghrelin O-Acyltransferase-Ghrelin system reduces TNF-α-Induced apoptosis and autophagy in human visceral adipocytes

    Diabetologia, Vol. 55, Núm. 11, pp. 3038-3050

2011

  1. Relación entre las fases precoces de la enfermedad renal y el síndrome metabólico

    Revista Espanola de Cardiologia, Vol. 64, Núm. 5, pp. 373-378

2010

  1. Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 298, Núm. 5

2008

  1. Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 294, Núm. 1

  2. The proinflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin

    Journal of Clinical Endocrinology and Metabolism, Vol. 93, Núm. 6, pp. 2319-2327

2007

  1. Plasma osteopontin levels and expression in adipose tissue are increased in obesity

    Journal of Clinical Endocrinology and Metabolism, Vol. 92, Núm. 9, pp. 3719-3727

1984

  1. Estenosis aórtica calcificada y hemorragia gastrointestinal recidivante, controlada con reemplazamiento valvular aórtico.

    Medicina Clinica, Vol. 83, Núm. 2, pp. 67-70